Impact of antiviral therapy for disease progression and non-invasive liver fibrosis index in patients with chronic hepatitis C: Markov chain model analysis.

Shun Kaneko Masayuki KurosakiAkemi KurisuTomoyuki AkitaJunko TanakaTatsuya Kanto

Published in: Hepatology research : the official journal of the Japan Society of Hepatology (2022)

Markov model analysis of hepatitis C virus patients showed the impact of antiviral therapy on the suppression of disease progression in the order of CH, CLC, and DLC.

Keyphrases

liver fibrosis
hepatitis c virus
end stage renal disease
newly diagnosed
chronic kidney disease
human immunodeficiency virus
peritoneal dialysis
prognostic factors
stem cells
bone marrow
patient reported
antiretroviral therapy
replacement therapy